Capital International Investors Has Boosted Seattle Genetics (SGEN) Stake by $93.73 Million; Valuation Rose; Egerton Capital Uk Llp Increases Holding in Praxair (PX)

January 14, 2018 - By Hazel Jackson

John Armitage increased its stake in Praxair Inc (PX) by 24.01% based on its latest 2017Q3 regulatory filing with the SEC. Egerton Capital Uk Llp bought 655,456 shares as the company’s stock rose 10.06% with the market. The hedge fund run by John Armitage held 3.38 million shares of the basic industries company at the end of 2017Q3, valued at $473.02M, up from 2.73 million at the end of the previous reported quarter. Egerton Capital Uk Llp who had been investing in Praxair Inc for a number of months, seems to be bullish on the $47.00B market cap company. The stock increased 0.21% or $0.34 during the last trading session, reaching $164.15. About 2.64 million shares traded or 58.01% up from the average. Praxair, Inc. (NYSE:PX) has risen 17.42% since January 14, 2017 and is uptrending. It has outperformed by 0.72% the S&P500.

Capital International Investors increased its stake in Seattle Genetics Inc (SGEN) by 63.7% based on its latest 2017Q3 regulatory filing with the SEC. Capital International Investors bought 1.74M shares as the company’s stock rose 1.68% with the market. The institutional investor held 4.46M shares of the health care company at the end of 2017Q3, valued at $242.68M, up from 2.72M at the end of the previous reported quarter. Capital International Investors who had been investing in Seattle Genetics Inc for a number of months, seems to be bullish on the $7.54B market cap company. The stock increased 1.12% or $0.58 during the last trading session, reaching $52.36. About 926,614 shares traded. Seattle Genetics, Inc. (NASDAQ:SGEN) has risen 75.68% since January 14, 2017 and is uptrending. It has outperformed by 58.98% the S&P500.

Capital International Investors, which manages about $83.48B US Long portfolio, decreased its stake in Xilinx Inc (NASDAQ:XLNX) by 670,800 shares to 2.69M shares, valued at $190.55M in 2017Q3, according to the filing. It also reduced its holding in Boeing Co (NYSE:BA) by 194,799 shares in the quarter, leaving it with 5.01M shares, and cut its stake in Newell Brands Inc (NYSE:NWL).

Since August 7, 2017, it had 0 insider purchases, and 17 insider sales for $9.99 million activity. The insider SIEGALL CLAY B sold 25,506 shares worth $1.22M. Cline Darren S also sold $85,635 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) on Monday, August 28. DRACHMAN JONATHAN G had sold 8,502 shares worth $407,199. $236,455 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) shares were sold by SIMPSON TODD E. $255,900 worth of Seattle Genetics, Inc. (NASDAQ:SGEN) shares were sold by DOBMEIER ERIC.

Among 18 analysts covering Seattle Genetics (NASDAQ:SGEN), 7 have Buy rating, 0 Sell and 11 Hold. Therefore 39% are positive. Seattle Genetics had 56 analyst reports since July 31, 2015 according to SRatingsIntel. Credit Suisse downgraded the shares of SGEN in report on Monday, December 12 to “Neutral” rating. The firm has “Hold” rating by Oppenheimer given on Monday, June 26. The firm has “Hold” rating given on Monday, July 24 by Oppenheimer. As per Monday, June 19, the company rating was maintained by Needham. The stock of Seattle Genetics, Inc. (NASDAQ:SGEN) earned “Outperform” rating by RBC Capital Markets on Friday, July 31. The rating was maintained by Oppenheimer on Tuesday, August 29 with “Hold”. The firm has “Buy” rating given on Monday, June 12 by Jefferies. The rating was maintained by Cantor Fitzgerald with “Hold” on Monday, June 19. The company was maintained on Friday, October 27 by Piper Jaffray. H.C. Wainwright maintained it with “Buy” rating and $75.0 target in Friday, October 27 report.

Investors sentiment decreased to 0.78 in 2017 Q3. Its down 0.52, from 1.3 in 2017Q2. It dropped, as 51 investors sold SGEN shares while 74 reduced holdings. 29 funds opened positions while 69 raised stakes. 140.23 million shares or 2.00% more from 137.48 million shares in 2017Q2 were reported. State Street Corporation holds 0.02% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN) for 3.23 million shares. Fmr Ltd Com holds 0.05% or 7.14M shares. Sumitomo Mitsui Tru Holding reported 280,692 shares or 0.02% of all its holdings. Next Financial Gru has 0% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 50 shares. Gru One Trading Lp has invested 0.02% in Seattle Genetics, Inc. (NASDAQ:SGEN). State Board Of Administration Of Florida Retirement reported 0.02% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Keybank Natl Association Oh reported 6,935 shares or 0% of all its holdings. Mufg Americas Corp invested in 0% or 100 shares. Td Asset Mngmt invested 0% of its portfolio in Seattle Genetics, Inc. (NASDAQ:SGEN). Ecor1 Capital Lc owns 30,000 shares or 0.22% of their US portfolio. Vanguard Grp Incorporated Incorporated accumulated 7.67M shares or 0.02% of the stock. Northwestern Mutual Wealth Mgmt owns 235 shares. Connecticut-based Fairfield Bush And Commerce has invested 0.29% in Seattle Genetics, Inc. (NASDAQ:SGEN). California-based Lpl Ltd Liability Co has invested 0% in Seattle Genetics, Inc. (NASDAQ:SGEN). Weiss Multi owns 0.03% invested in Seattle Genetics, Inc. (NASDAQ:SGEN) for 15,000 shares.

Egerton Capital Uk Llp, which manages about $14.07B and $11.18B US Long portfolio, decreased its stake in Schwab Charles Corp New (NYSE:SCHW) by 52,755 shares to 10.67 million shares, valued at $466.67M in 2017Q3, according to the filing. It also reduced its holding in Martin Marietta Matls Inc (NYSE:MLM) by 217,485 shares in the quarter, leaving it with 1.75 million shares, and cut its stake in Canadian Pac Ry Ltd (NYSE:CP).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts